Professional Marketing briefs: October 2012

Share this article:
Professional Marketing briefs: October 2012
Professional Marketing briefs: October 2012

Content Marketing Institute and MedCityNews.com are holding their first Content Marketing World Summit in November. The ­November 7–8 meeting will be held in Cleveland, OH, and will focus on healthcare marketing. Topics will include social media and content creation for hospitals, content marketing metrics and ROI and managing the content marketing process.

Sanofi was expected to clarify layoff plans at meetings September 25 and October 3, reported Reuters, which attributed the information to union sources. Unions said they expect Sanofi to cut about 2,500 research and support jobs in France. Sanofi told ­Reuters meeting dates had not been set, but that is presenting its employment plans to the works council in September.

Although the FDA is on a roll of obesity-drug approvals, word is that branded slimming drugs may have competition, reported the Associated Press. The wire service quoted analyst Thomas Wei as saying he believes doctors will prescribe Qsymia's components instead of the branded drug. Qsymia consists of topiratmate and phentermine, both of which are available as generics.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.